Results 211 to 220 of about 408,639 (386)

Clinical Experience with a New Oral Contraceptive

, 1963
Donald Swartz, James Walters, E. R. PLUNKETT, R. A. H. Kinch   +3 more
openalex   +1 more source

Tryptophan and oral contraceptives. [PDF]

, 1969
P. A. Toseland, SarahA Price
openalex   +1 more source

Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

American Journal of Hematology, EarlyView.
ABSTRACT Selecting the optimal donor is crucial for optimizing results of allogeneic hematopoietic cell transplantation (allo‐HCT). We analyzed outcomes based on donor type in 2809 myelofibrosis (MF) patients undergoing first allo‐HCT between 2015 and 2021 at EBMT centers.
Juan Carlos Hernández‐Boluda, Vipul Sheth, Simona Iacobelli, Linda Koster, Nicolaus Kröger, Patrizia Chiusolo, Thomas Schroeder, Marie Robin, Massimiliano Gambella, Didier Blaise, Henrik Sengeloev, Jakob Passweg, Mattias Stelljes, Robert Zeiser, Ibrahim Yakoub‐Agha, Andrew Clark, Urpu Salmenniemi, Piero Galieni, Werner Rabisch, Kavita Raj, Joanna Drozd‐Sokolowska, Giorgia Battipaglia, Nicola Polverelli, Tomasz Czerw, Donal P. McLornan   +24 more
wiley   +1 more source

Oral Contraceptives and Liver Damage [PDF]

, 1964
H. Adlercrutz, E. Ikonen
openalex   +3 more sources

Determinants of modern contraceptive use among married women of reproductive age in ethiopia: a cross-sectional analysis of the 2019 Ethiopian mini demographic and health survey. [PDF]

Sci Rep
Merera AM, Lelisho ME, Sheferaw WE.
europepmc   +1 more source

Insulin and Glucose Determinations After Two and Three Years of Use of a Combination-Type Oral Contraceptive

, 1969
William N. Spellacy, Richard P. Bendel, William C. Buhi, S.A. Birk   +3 more
openalex   +1 more source

ORAL CONTRACEPTIVES AND CÆRULOPLASMIN ACTIVITY [PDF]

, 1968
M. H. K. Shokeir
openalex   +1 more source

Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 Patients

American Journal of Hematology, EarlyView.
ABSTRACT Only few data are available regarding the efficacy and safety of thrombopoietin receptor agonists (TPO‐RAs) for treating systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS)‐associated immune thrombocytopenia (ITP). We retrospectively assessed the efficacy and safety of TPO‐RAs in 80 adults with ITP in three subgroups: (1)
Cindy Marques, Guillaume Moulis, Mickaël Roussotte, Bernard Bonnotte, Jean‐François Viallard, Julie Graveleau, Hervé Lobbes, Nathalie Costedoat‐Chalumeau, Alban Deroux, Delphine Gobert, Antoine Dossier, Laurent Gilardin, Olivier Lambotte, Mylène Dufrenoy, Matthieu Mahévas, Marc Michel, Pascal Sève, Bertrand Godeau   +17 more
wiley   +1 more source

Sociodemographic factors associated with modern contraceptive use in Japan: an analysis of national survey data. [PDF]

Contracept Reprod Med
Okui T.
europepmc   +1 more source

Evaluation of a New Combination Oral Contraceptive: Lynestrenol-Mestranol (Lyndiol)

, 1969
Louis E. Moses, Joseph W. Goldzieher, Ida G. Moses   +2 more
openalex   +1 more source